FMED | IBB | FMED / IBB | |
Gain YTD | -4.122 | -5.657 | 73% |
Net Assets | 50.2M | 5.32B | 1% |
Total Expense Ratio | 0.50 | 0.45 | 111% |
Turnover | 33.00 | 22.00 | 150% |
Yield | 0.48 | 0.30 | 159% |
Fund Existence | 5 years | 24 years | - |
FMED | IBB | |
---|---|---|
RSI ODDS (%) | 1 day ago62% | 1 day ago83% |
Stochastic ODDS (%) | 1 day ago77% | 1 day ago87% |
Momentum ODDS (%) | 1 day ago77% | 1 day ago83% |
MACD ODDS (%) | 1 day ago81% | 1 day ago80% |
TrendWeek ODDS (%) | 1 day ago78% | 1 day ago84% |
TrendMonth ODDS (%) | 1 day ago84% | 1 day ago88% |
Advances ODDS (%) | 1 day ago80% | 6 days ago86% |
Declines ODDS (%) | 9 days ago79% | 14 days ago85% |
BollingerBands ODDS (%) | 1 day ago71% | 1 day ago90% |
Aroon ODDS (%) | 1 day ago85% | 1 day ago86% |
A.I.dvisor indicates that over the last year, FMED has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if FMED jumps, then DHR could also see price increases.
Ticker / NAME | Correlation To FMED | 1D Price Change % | ||
---|---|---|---|---|
FMED | 100% | +0.22% | ||
DHR - FMED | 67% Closely correlated | -0.62% | ||
TMO - FMED | 63% Loosely correlated | -0.68% | ||
TECH - FMED | 63% Loosely correlated | +0.02% | ||
ISRG - FMED | 63% Loosely correlated | -0.11% | ||
SYK - FMED | 61% Loosely correlated | +0.39% | ||
More |
A.I.dvisor indicates that over the last year, IBB has been loosely correlated with REGN. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if IBB jumps, then REGN could also see price increases.
Ticker / NAME | Correlation To IBB | 1D Price Change % | ||
---|---|---|---|---|
IBB | 100% | +1.14% | ||
REGN - IBB | 66% Loosely correlated | +1.36% | ||
DNLI - IBB | 63% Loosely correlated | +3.64% | ||
BIIB - IBB | 62% Loosely correlated | +0.24% | ||
RCKT - IBB | 60% Loosely correlated | -0.97% | ||
TECH - IBB | 60% Loosely correlated | +0.02% | ||
More |